SUB-Q
SUB-Q, licence 80086458: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Sub-Q V. 3
- Licence holder
- Fusion Nutrition Inc.
- NPN or DIN-HM
- 80086458
- Status
- Active licence
- Licence date
- 20 June 2018
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 4-(4-hydroxyphényl)-2-butanone Source : Raspberry ketone | 50.0 mg | Not calculated |
| 1,3,7-Triméthylxanthine Source : Caféine | 66.6 mg | Not calculated |
| L-Valine Source : L-valine | 60.0 mg | Not calculated |
| Acide pantothénique Source : D-Pantothénate de calcium | 1.67 mg | 6,680 µg |
| L-isoleucine Source : L-valine | 60.0 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, phosphate de dicalcium, Croscarmellose de sodium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Comprimé | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Source of antioxidants. Source of branched chain amino acids (BCAAs), which are involved in protein synthesis. Assists in the building of lean muscle mass when combined with regular weight training and healthy balanced diet. Source of essential amino acids involved in muscle protein synthesis. Helps to maintain the body's ability to metabolize nutrients.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80086458
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.